Prelude Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,000
Closed -$187K 1516
2026
Q1
$187K Buy
10,000
+1,020
+11% +$19.5K 0.01% 926
2025
Q4
$207K Sell
8,980
-146,310
-94% -$3.77M 0.02% 1043
2025
Q3
$4.17M Buy
+155,290
New +$3.7M 0.33% 53
2022
Q4
Sell
-6,957
Closed -$491K 1597
2022
Q3
$491K Buy
+6,957
New +$595K 0.02% 666
2020
Q2
Sell
-250
Closed -$8K 2236
2020
Q1
$8K Sell
250
-634
-72% -$21.4K ﹤0.01% 1169
2019
Q4
$31K Buy
+884
New +$29.2K ﹤0.01% 1490
2019
Q2
Sell
-784
Closed -$27K 2117
2019
Q1
$27K Sell
784
-2,508
-76% -$88.7K ﹤0.01% 1264
2018
Q4
$105K Buy
3,292
+2,616
+387% +$102K 0.01% 914
2018
Q3
$32K Sell
676
-324
-32% -$13.3K ﹤0.01% 1228
2018
Q2
$31K Sell
1,000
-500
-33% -$11.7K ﹤0.01% 1251
2018
Q1
$22K Sell
1,500
-139
-8% -$2.17K ﹤0.01% 1249
2017
Q4
$25K Buy
1,639
+1,056
+181% +$15.7K ﹤0.01% 1091
2017
Q3
$7K Sell
583
-178
-23% -$1.99K ﹤0.01% 1473
2017
Q2
$8K Buy
+761
New +$7.44K ﹤0.01% 1431
2014
Q1
Sell
-280
Closed -$5K 2097
2013
Q4
$5K Sell
280
-20
-7% -$268 ﹤0.01% 1554
2013
Q3
$4K Buy
+300
New +$3.53K ﹤0.01% 1542

Other funds holding STAA

Prelude Capital Management's STAA Position: Q2 2026 in Review

Prelude Capital Management sold out of STAAR Surgical (STAA) in Q2 2026, closing a stake of 10,000 shares — an estimated $187K sold.

Prelude Capital Management first reported a position in STAA in Q3 2013 and held it in 16 quarters. The position peaked at $4.17M in Q3 2025. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Prelude Capital Management reported no remaining STAAR Surgical position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 10,000 STAAR Surgical shares in Q2 2026, an estimated $187K.
  • Prelude Capital Management first reported a position in STAAR Surgical in Q3 2013 and held it in 16 quarters.
  • Prelude Capital Management's STAAR Surgical position peaked at $4.17M in Q3 2025.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.